GlassScriptPhysician profile
Diana C Mong
NPI 1922365410
$508.58
in general payments reported to CMS, 2019-2025
12 companies · $85.90 in 2025
The $85.90 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.10 · 2020: $90.84 · 2021: $52.47 · 2022: $48.98 · 2023: $36.15 · 2024: $97.14 · 2025: $85.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $188.68 | 2019-2023 | |
| Organon LLC | $59.91 | 2023-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $47.29 | 2024 | Myfembree |
| Merck Sharp & Dohme LLC | $37.51 | 2021-2024 | Gardasil, Gardasil 9 |
| Lupin INC. | $35.25 | 2020 | |
| Exeltis, USA INC. | $28.12 | 2020 | |
| Mayne Pharma Commercial LLC | $23.99 | 2025 | |
| Optumhealth Care Solutions, LLC | $22.14 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Meditrina | $20.43 | 2025 | |
| Astellas Pharma US INC | $16.00 | 2024 | Veozah |
| Coopersurgical, INC. | $15.77 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $13.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Mong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.